Cancer BiologyJournal of Clinical InvestigationPeer-reviewed
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma.
Saireudee Chaturantabut, Sydney Oliver, Dennie Tompers Frederick…·William R. Sellers
The paper identifies biparatopic antibodies targeting FGFR2 extracellular domain that effectively block FGFR2 fusion-driven cholangiocarcinoma signaling and growth.
5 citations